-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
180 Life Sciences Corp. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2019 to 2024.
- 180 Life Sciences Corp. Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $2.3M.
- 180 Life Sciences Corp. annual Deferred Income Tax Expense (Benefit) for 2024 was -$292K, a 87.6% increase from 2023.
- 180 Life Sciences Corp. annual Deferred Income Tax Expense (Benefit) for 2023 was -$2.35M, a 149% decline from 2022.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)